Consolidated Statements of Cash Flow (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net (Loss)	$ (3,973,806)	$ (3,268,093)
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:
Depreciation and amortization	329,478	129,060
Loss on vendor notes receivable foreclosure		(135,000)
Imputed interest		46,340
Debt discount amortization	11,505
Stock grants	496,143
Stock for services	22,350	330,625
Employee stock awards	644,724	160,000
Warrants for services and interest		113,188
Gain on bargain purchase of assets	(1,599,161)
Changes in Current Assets and Liabilities
Accounts receivable	611,740	(173,893)
Allowance for doubtful accounts	(9,000)	26,046
Due to (from) related parties	(11,354)	(18,461)
Inventories	(1,546,301)	(163,442)
Prepaid expenses	38,213	173,254
Deposits	(39,115)
Accounts payable	(113,389)	99,531
Accrued liabilities	(66,413)	167,989
Net cash used in operating activities	(5,204,386)	(2,512,856)
Cash flows from investing activities
Purchase of equipment	(1,629,833)	(268,171)
Purchase of patent	(250,000)	(100,000)
Net cash used in investing activities	(1,879,833)	(368,171)
Cash flow from financing activities
Convertible note payment		(300,000)
Note payment - related party		(598,000)
Insurance premium note payment	(99,907)	(127,705)
Contingent consideration payment	(50,000)
Convertible promissory note	1,534,000
Sale of common stock	3,591,030	4,688,025
Purchase of common stock	(124,000)
Common stock issued for exercised warrants	4,767,625
Collection of stock subscription		167,500
Common stock activity - founders shares		(99,355)
Organizational and fundraising costs	(872,870)	(162,750)
Net cash provided by financing activities	8,745,878	3,567,715
Net increase in cash	1,661,659	686,688
Cash, beginning of period	4,381,643	100,135
Cash, end of period	6,043,302	786,823
Supplemental cash flow disclosures
Cash paid during the period for - Interest	11,976	7,808
Cash paid during the period for - Income taxes
Non-cash investing and financing activities:
Additional paid-in-capital	(11)
Common stock	11
Issuance of common stock	4,624,005
Contingent consideration payable	1,250,000
Patent acquisition	(5,874,005)
Prepaid legal services		(224,000)
Issuance of common stock		224,000
Notes payable - related parties		100,000
Issuance of common stock		750,000
Patent acquisitions		(850,000)
Stock subscription receivable		(5,000)
Additional paid-in-capital		5,000
Total non-cash investing and financing activities